The challenge of patient education traditionally is a responsibility of nurses. The nursing process of assessing, planning, implementing and evaluating is never more appropriate than when teaching patients and families about cancer treatments. In the past, as patients prepared for traditional IV (intravenous) treatment, nurses had a 'captured audience' to teach and the opportunity to then reinforce repeated verbal instructions and written materials, slowly and thoroughly reviewing procedures and potential problems. Plus, nurses had ample opportunities to physically see and touch patients throughout the course of their treatments in order to assess for treatment side effects and disease symptoms. However, today, patients prescribed oral chemotherapy may never see a nurse. The physician may write a prescription, which is then filled by a pharmacist. 
study was to identify the nursing role in providing education and follow-up for patients receiving oral chemotherapy treatment in oncology clinics in Turkey. Kav noted that oral cancer agents increasingly were part of treatment regimens and that administration occurred outside of the traditional controlled settings of clinic, practice or hospital. Therefore, it was urgent to assess the role of nurses involved. One hundred and two nurses from 16 cities in Turkey completed a questionnaire. The study indicated that 73 % of nurses polled had no guidelines and 97 % no teaching tools. 6 The MASCC Education Study Group wondered if this dismal result was confined to Turkey, or if, in fact, the lack of specific education guidelines and tools for patients receiving oral agents was a worldwide phenomenon. The MASCC is an organisation with members from over 60 countries and the Education Study Group had been involved previously in other international projects. The group replicated the Kav and Bostanci study and, between 2005 and 2007, nurses and pharmacy co-ordinators from 15 countries collected data from 1,115 nurses worldwide. 7 Results showed that, although 52 % of those surveyed had some type of guideline or protocol, 47 % reported not receiving any education at all regarding teaching patients about oral chemotherapy agents. Additionally, 64 % reported involvement in patient education, but 58 % had no teaching materials specific to oral agents. Only 27 % stated that they gave all the necessary information, such as when and how to take the medications, drug safety and storage, and potential side effects and their management. Poor education and follow-up were evident, and professional education for nurses as well as patient education materials were requested. 7 The lack of any standard procedure to prescribe and manage oral agents was being noted by others as well during this period. 
Final Product -Implementing
The MOATT consists of four sections detailed below. To date, as well as being available in English, the MOATT has been translated and adapted into eleven other languages (see Table 2 ), all of which can be downloaded from the MASCC website (www.mascc.org).
The MOATT in Practice -Evaluation
Following the 'Train the Trainer' workshop, clinical implementation and evaluations of the MOATT involving education of 635 patients and care-givers by 114 nurses were completed in China, Denmark, Greece, Kenya, Spain, Turkey and the US. Table 3 shows the results of the evaluations from those countries.
The MOATT has been cited in numerous articles as a valuable tool. [16] [17] [18] [19] [20] [21] [22] Additionally, it has been incorporated in research projects. 23, 24 MOATT group leaders communicate on a routine basis to evaluate and plan for future uses and dissemination. Based on critiques received, a MOATT User Guide has been developed and is available on the MASCC website.
Discussion
Problems remain for patients requiring oral chemotherapy agents, (sixth from top). 25 Streeter et al. calculated the abandonment rate of oral oncolytics in a cross-sectional study using administrative claims data, finding cost a major factor. 26 Khandelwal's group studied ways to minimise this waste, recommending dose-monitoring programmes that will reduce waste and serious adverse effects. 3 information, proper follow-up and surveillance. 19 Given and colleagues elucidated almost the same issues, adding outcome expectations, health literacy, disease type and stage, and out-of-pocket costs. 28 Moore and Winklejohn discussed factors such as patient history, motivation and relationship with the healthcare provider as important in promoting adherence. When stressing the importance of individualised patient education, these authors recommended the MOATT as a resource.
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Conclusion
In the best of circumstances, educating patients and families about chemotherapy, IV or oral, is a challenge. The healthcare community has risen to challenges in the past and continues to make adjustments and improvements. Using evidence-based tenets in patient education along with adapting teaching to each patient's situation, nurses are recognising and dealing with challenges of the new paradigm of oral chemotherapeutic agents. The MOATT is an easy-to-use, well researched, refined and internationally available tool. As professionals implement teaching with the MOATT, outcomes should benefit many, but most importantly cancer patients themselves. n
